38.48 USD
↘ 0.42 (1.08%)AT CLOSE (11:59 AM EDT)
Veracyte, Inc.
VCYTNASDAQ • USD
38.49
↗ 0.01 (0.01%)
POST MARKET (AS OF 05:36 PM EDT)
Post Market
AS OF 05:36 PM EDT
38.49
↗ 0.01 (0.01%)
Market: CLOSED
Open?$38.17
High?$39.57
Low?$37.72
Prev. Close?$38.90
Volume?944.8K
Avg. Volume?885.9K
VWAP?$38.78
Rel. Volume?1.07x
Bid / Ask
Bid?$33.54 × 100
Ask?$43.96 × 100
Spread?$10.42
Midpoint?$38.75
Valuation & Ratios
Market Cap?3.1B
Shares Out?79.8M
Float?77.9M
Float %?98.6%
P/E Ratio?34.89
P/B Ratio?2.28
EPS?$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Themes
Employees
755
Market Cap
3.1B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2013-10-30
Address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.31Strong
Quick Ratio?8.92Strong
Cash Ratio?4.69Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?34.9PRICEY▾
P/B?2.28CHEAP▾
P/S?5.67FAIR▾
P/FCF?19.8CHEAP▾
EV/EBITDA?23.5HIGH▾
EV/Sales?5.18FAIR▾
Returns & Efficiency
ROE?6.6%FAIR▾
ROA?6.1%FAIR▾
Cash Flow & Enterprise
FCF?$155.3M
Enterprise Value?$2.8B
Fundamentals ratios updated end of day